Product image 1

Breast gland with strong nuclear MRE11 staining of all cells. (Startbild)

Staining Pattern in Normal Tissues

Manual protocol

Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121°C in pH 7,8 Target Retrieval Solution buffer. Apply HMV328 at a dilution of 1:200 at 37°C for 60 minutes. Visualization of bound antibody by the EnVision Kit (Dako, Agilent) according to the manufacturer’s directions.

Brain
CerebrumDistinct nuclear MRE11 staining of all cells.
CerebellumVariable nuclear MRE11 staining of all cells. The staining is strongest in Purkinje cells while it is rather weak in the granule cell layer.
Endocrine tissues
ThyroidStrong nuclear MRE11 staining of all cells.
ParathyroidStrong nuclear MRE11 staining of all cells.
Adrenal glandDistinct nuclear MRE11 staining of all cells.
Pituitary glandDistinct nuclear MRE11 staining of all cells.
Respiratory system
Respiratory epitheliumStrong nuclear MRE11 staining of all cells.
LungStrong nuclear MRE11 staining of all cells.
Gastrointestinal tract
Salivary glandsStrong nuclear MRE11 staining of all cells.
EsophagusStrong nuclear MRE11 staining of all cells. Slight decrease of MRE11 staining of squamous epithelium from the basal/suprabasal to the superficial cell layers.
StomachStrong nuclear MRE11 staining of all cells. A distinct cytoplasmic MRE11 staining of parietal cells represents a (tolerable) cross-reactivity.
DuodenumStrong nuclear MRE11 staining of all cells.
Small intestineStrong nuclear MRE11 staining of all cells.
AppendixStrong nuclear MRE11 staining of all cells.
ColonDistinct nuclear MRE11 staining of all cells. Slight but significant decrease of MRE11 staining from the crypt base to the superficial epithelial cell layers.
RectumDistinct nuclear MRE11 staining of all cells. Slight but significant decrease of MRE11 staining from the crypt base to the superficial epithelial cell layers.
Liver, Gallbladder, Pancreas
LiverNuclear MRE11 staining of most cells. Staining is clearly weakest in hepatocytes where it varies from negative to moderate.
GallbladderStrong nuclear MRE11 staining of all cells.
PancreasStrong nuclear MRE11 staining of all cells.
Genitourinary
KidneyStrong nuclear MRE11 staining of all cells.
UrotheliumStrong nuclear MRE11 staining of all cells.
Male tissues
ProstateStrong nuclear MRE11 staining of all cells.
Seminal VesiclesStrong nuclear MRE11 staining of all cells.
TestisStrong nuclear MRE11 staining of all cells. Additional cytoplasmic staining of one tubular cell type (Sertoli cells?). The staining intensity of germ cells decreases from spermatogonia to spermatids.
EpididymisStrong nuclear MRE11 staining of all cells.
Female tissues
BreastStrong nuclear MRE11 staining of all cells.
Uterus, myometriumStrong nuclear MRE11 staining of all cells.
Uterus, ectocervixStrong nuclear MRE11 staining of all cells.
Uterus, endocervixStrong nuclear MRE11 staining of all cells.
Uterus, endometriumStrong nuclear MRE11 staining of all cells.
Fallopian tubeStrong nuclear MRE11 staining of all cells.
OvaryStrong nuclear MRE11 staining of all cells.
Placenta earlyStrong nuclear MRE11 staining of all cells. Some cytoplasmic staining of trophoblast cells does also occur.
Placenta matureNuclear MRE11 staining of all cells. However, the nuclear staining is somewhat weaker in syncytiotrophoblast cells than in all other cell types.
AmnionStrong nuclear MRE11 staining of all cells.
ChorionStrong nuclear MRE11 staining of all cells.
Skin
EpidermisStrong nuclear MRE11 staining of all cells.
Sebaceous glandsStrong nuclear MRE11 staining of all cells.
Muscle, connective & soft tissues
Heart muscleStrong nuclear MRE11 staining of all cells.
Skeletal muscleStrong nuclear MRE11 staining of all cells.
Smooth muscleStrong nuclear MRE11 staining of all cells. A weak to moderate cytoplasmic MRE11 staining occurs in some samples.
Vessel wallsStrong nuclear MRE11 staining of all cells.
FatStrong nuclear MRE11 staining of all cells.
StromaStrong nuclear MRE11 staining of all cells.
EndotheliumStrong nuclear MRE11 staining of all cells.
Bone marrow & lymphoid tissues
Bone marrowStrong nuclear MRE11 staining of all cells.
Lymph nodeStrong nuclear MRE11 staining of all cells.
SpleenStrong nuclear MRE11 staining of all cells.
ThymusStrong nuclear MRE11 staining of all cells. A few dispersed cells stand out because of a particularly strong nuclear MRE11 staining.
TonsilStrong nuclear MRE11 staining of all cells.
Remarks

The vast majority of cell types show a strong MRE11 staining in the nuclei.

MRE11

(HMV328)

MRE11 is Critical for DNA double strand break repair.

Select Format
Select Volume
From €295.00
excl. shipping costs and taxes
MRE11 (HMV328)
€295.00

Details

Type
Recombinant Rabbit monoclonal / IgG
Clone
HMV328
Reactivity
Human

More product details

Biology behind

Double-strand break repair protein MRE11 (also named MRE11A) is an 80,6 kDa (predominant isoform) protein coded by the MRE11 gene on chromosome 11q21. Together with RAD50 and NBS1, MRE11 forms the MRN complex which is a key element in DNA damage response (DDR) and possesses both single-stranded DNA endonuclease and 3′ to 5′ exonuclease activities. The MRN complex is an early sensor for locating double strand DNA breaks (DSBs) and plays a direct role in both DSB repair and the recruiting of DDR proteins and activation of their downstream signaling. It regulates repair of DNA double-strand breaks in several contexts, including replication, telomere homeostasis, meiosis, apoptosis and immune system development. The MRN complex is involved in multiple different pathways of DSBs repair, including homologous recombination (HR), non-homologous end joining (NHEJ) and the (most error prone) pathway of microhomology-mediated end joining (MMEJ) repair. MRE11 is one of 6 enzymes required for MMEJ. MRE11 and the MRN complex are thought to play a key role in cancer radiosensitivity. MRE11 overexpressing cancers are generally considered to be more radioresistant and low-expressors are regarded as chemo-sensitive although this rule may not apply to all cancer types. Several MRE11 inhibitors are currently investigated in clinical trials as radiosensitizers.

Protocol Recommendations

Potential Research Applications

Evidence For Antibody Specificity In I H C